Alpha Teknova Inc (TKNO)

Currency in USD
7.380
-0.010(-0.14%)
Closed·
7.450+0.070(+0.95%)
·
Unusual trading volume
Trading near 52-week High
TKNO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.3507.840
52 wk Range
1.9107.840
Key Statistics
Prev. Close
7.39
Open
7.37
Day's Range
7.35-7.84
52 wk Range
1.91-7.84
Volume
843.12K
Average Vol. (3m)
194.91K
1-Year Change
53.75%
Book Value / Share
1.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TKNO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.600
Upside
+16.53%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Alpha Teknova Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.600
(+16.53% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Buy8.00+8.40%-UpgradeAug 11, 2026
Roth/MKM
Buy7.00-5.15%-New CoverageAug 05, 2026
BTIG
Hold---MaintainMay 14, 2026

Alpha Teknova Inc Earnings Call Summary for Q2/2026

  • Teknova reported Q2 2026 revenue of $12.2M, up 18% YoY and beating estimates by 11%, marking the highest quarterly revenue in 30 years.
  • Adjusted loss per share of $0.06 beat forecasts by 25%; gross margin improved to 40.1% from 38.7%, while free cash outflow fell to $0.6M.
  • Full-year 2026 revenue guidance raised to $45M-$47M from $42M-$44M; company expects EBITDA profitability at $52M-$57M annual revenue run-rate.
  • Launched Build-Tek, an AI-powered custom order configurator, to accelerate custom product capabilities without direct monetization plans.
  • Stock dipped 0.53% after-hours to $5.58 despite beats, as investors weigh timing risks for 2027 growth drivers including biotech funding and therapy commercialization.
Last Updated: 08/05/2026, 07:11 PM
Read Full Transcript
Alpha Teknova investor slides for Q2/2026
Teknova Q2 2026 slides
Last Update: Aug 05, 2026
See full investor slides

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
-0.06 / -0.08
Revenue / Forecast
12.2M / 10.98M
EPS Revisions
Last 90 days

TKNO Income Statement

Compare TKNO to Peers and Sector

Metrics to compare
TKNO
Peers
Sector
Relationship
P/E Ratio
−23.6x−5.8x−0.3x
PEG Ratio
−1.04−0.090.00
Price / Book
6.3x4.2x2.6x
Price / LTM Sales
9.1x3.8x3.1x
Upside (Analyst Target)
8.3%15.0%48.3%
Fair Value Upside
Unlock3.9%6.7%Unlock

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.06M7.58%30.02M
Other Institutional Investors
79.25M92.42%585.63M
Public Companies & Retail Investors
0.000.00%0.00
Total
83.31M100.00%615.65M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Telegraph Hill Partners70.35%37,717,565278,733
Telegraph Hill Partners IV, L.P.49.60%26,590,636196,505

People Also Watch

5.010
ASRV
+0.80%
43.90
FSBW
+0.25%
8.270
LNSR
+31.48%

FAQ

What Is the Alpha Teknova (TKNO) Stock Price Today?

The Alpha Teknova stock price today is 7.380 USD.

What Stock Exchange Does Alpha Teknova Trade On?

Alpha Teknova is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Alpha Teknova?

The stock symbol for Alpha Teknova is "TKNO."

What Is the Alpha Teknova Market Cap?

As of today, Alpha Teknova market cap is 396.760M USD.

What Is Alpha Teknova's Earnings Per Share (TTM)?

The Alpha Teknova EPS (TTM) is -0.313.

When Is the Next Alpha Teknova Earnings Date?

Alpha Teknova will release its next earnings report on Nov 05, 2026.

From a Technical Analysis Perspective, Is TKNO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Alpha Teknova Stock Split?

Alpha Teknova has split 0 times.

How Many Employees Does Alpha Teknova Have?

Alpha Teknova has 158 employees.

What is the current trading status of Alpha Teknova (TKNO)?

As of Aug 14, 2026, Alpha Teknova (TKNO) is trading at a price of 7.380 USD, with a previous close of 7.390 USD. The stock has fluctuated within a day range of 7.350 USD to 7.840 USD, while its 52-week range spans from 1.910 USD to 7.840 USD.

What Is Alpha Teknova (TKNO) Price Target According to Analysts?

The average 12-month price target for Alpha Teknova is 8.600 USD, with a high estimate of 12 USD and a low estimate of 7 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +16.53% Upside potential.

What Is the TKNO Premarket Price?

TKNO's last pre-market stock price is 7.380 USD. The pre-market share volume is 317.000, and the stock has decreased by -0.010, or -0.140%.

What Is the TKNO After Hours Price?

TKNO's last after hours stock price is 7.450 USD, the stock has decreased by 0.070, or 0.950%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.